Thursday, August 23, 2007
SansRosa / COL-118 Phase II "highly positive"
COL-118, Collagenex's topical (i.e. "cream" based) treatment for the redness and flushing associated with rosacea has had "highly positive" results in their Phase II studies. I was recently wondering what was happening with COL-118 and had started to suspect it was not progressing so this is suprising and pleasing news to me.
They are expecting Phase III trials to begin first quarter 2008.
http://phx.corporate-ir.net/phoenix.zhtml?c=65436&p=irol-newsArticle&ID=1043043&highlight=
Some quotes
"James Leyden, M.D., Professor Emeritus, University of Pennsylvania, and lead investigator of the study, said, “Col-118 appears to be the first effective treatment for the redness (flushing and blushing) associated with rosacea. Currently, there are no effective treatments for patients who suffer from this aspect of rosacea. If future studies confirm these results, this treatment should be approved by FDA. Once approved, Col-118 will offer an important new treatment to millions of rosacea patients.” "
I have written about SansRosa (as it was originally called) / COL-118 (as it is now called) many times before.
David at the Rosacea Support Group also writes about this story.
They are expecting Phase III trials to begin first quarter 2008.
http://phx.corporate-ir.net/phoenix.zhtml?c=65436&p=irol-newsArticle&ID=1043043&highlight=
Some quotes
"James Leyden, M.D., Professor Emeritus, University of Pennsylvania, and lead investigator of the study, said, “Col-118 appears to be the first effective treatment for the redness (flushing and blushing) associated with rosacea. Currently, there are no effective treatments for patients who suffer from this aspect of rosacea. If future studies confirm these results, this treatment should be approved by FDA. Once approved, Col-118 will offer an important new treatment to millions of rosacea patients.” "
I have written about SansRosa (as it was originally called) / COL-118 (as it is now called) many times before.
David at the Rosacea Support Group also writes about this story.
